This 7-year research program will clarify the mechanisms by which a different technology creation paradigm can contribute to healthcare sustainability, address the needs of a growing elderly population, support patients who are afflicted by chronic diseases and reduce health disparities through affordable and user-friendly innovations.

Scholarship in this area is warranted when one considers the capital-intensive nature of R&D and how high-tech services make “choosing wisely” [hyperlien section Canadienne] steadily more difficult.

Our findings will prove of strategic importance to health and innovation policymakers, entrepreneurs and investors. It can profoundly benefit patients and healthcare providers because it will evidence alternative ways of designing, financing and commercializing technologies.


To generate an empirically-grounded model of why and how responsible innovations are produced, this paper provides a synthesis of 17 qualitative studies describing the development of responsible innovations that have an incidence on the determinants of health.

Lehoux, P., Daudelin, G., Denis, J.-L., Gauthier, P., Hagemeister, N. (2019). Pourquoi et comment sont conçues des innovations responsables ? Résultats d’une méta-ethnographie. Revue d’économie et de management de l’innovation.

To identify the challenges that responsible innovation in health should seek to address, this papers presents the findings of a synthesis of 254 articles that examined the challenges of health systems in 99 countries.

Lehoux, P., Roncarolo, F., Silva, H.P., Boivin, A., Denis, J.-L., Hébert, R. (2019). What health system challenges should responsible innovation in health address? Insights from an international scoping review. International Journal of Health Policy and Management.

This paper shows how an international panel of experts contributed to the development of a Responsible Innovation in Health (RIH) screening and assessment Tool.

Silva, H. P., Lehoux, P., & Hagemeister, N. (2018). Developing a tool to assess responsibility in health innovation: Results from an international delphi studyHealth Policy and Technology.https://doi.org/10.1016/j.hlpt.2018.10.007.

With the help of empirical examples, this paper explores the relationships Responsible Innovation in Health (RIH) may entertain with the Sustainable Development Goals (SDG).

Lehoux, P., Pacifico Silva, H., Pozelli Sabio, R., & Roncarolo, F. (2018). The Unexplored Contribution of Responsible Innovation in Health to Sustainable Development Goals. Sustainability10(11), 4015. https://doi.org/10.3390/su10114015.

This article introduces an integrative RIH framework drawing on the RRI literature, the international literature on health systems as well as specific bodies of knowledge that shed light on key dimensions of health innovations.

Silva, H.P., Lehoux, P., Miller, F.A., Denis, J.-L. (2018). Introducing responsible innovation in health: a policy-oriented framework, Health Research Policy and Systems, doi: 10.1186/s12961-018-0362-5

Drawing on a prospective public deliberation study, this article offers sociological insights into the ways in which members of the public reason around assistive actions, be they performed by humans, machines or both.

Lehoux, P., Grimard, D. (2018). When robots care: Public deliberations on how technology and humans may support independent living for older adults, Social Science & Medicine, doi: 10.1016/j.socscimed.2018.06.038

This article looks at what kind of research was conducted on Health System challenges, where it was performed, in which health sectors and on which populations. It also identifies the types of challenge that were most present and how they varied across countries

Roncarolo, F., Boivin, A., Denis, J.-L., Hébert, R., Lehoux, P. (2017). What do we know about the needs and challenges of health systems? A scoping review of the international literature, BMC Health Services Research, doi: 10.1186/s12913-017-2585-5

This article examines the rules that characterize economic policy, capital investment, and regulatory approval as well as the way these institutions enable and constrain the development of ventures at an early stage.

Lehoux, P., Daudelin, G., Denis, J.-L., Miller F.A. (2017). A Concurrent Analysis of Three Institutions that Transform Health Technology-Based Ventures: Economic Policy, Capital Investment, and Market Approval, Review of Policy Research, doi: 10.1111/ropr.12246

Building on insights from sociology of expectations and institutions, this paper elicits how specific institutional requirements provide potency to the expectations that pave the health technology development pathway.

Lehoux, P., Miller, F.A., Daudelin, G. (2016). Converting clinical risks into economic value: The role of expectations and institutions in health technology development, Technological Forcasting and Social Change, doi: 10.1016/j.techfore.2016.11.026

The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.

Lehoux, P., Miller, F.A., Daudelin, G., Denis, J.L. (2017). Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies, Int J Health Policy Manag, doi:10.15171/ijhpm.2017.11
Consultez l’article en fomat PDF ici

This article seeks to deepen our understanding of the responsible research and innovation (RRI) approach as it relates to health care systems, where the notion of responsibility is already deeply embedded.

Demers-Payette, O., Lehoux, P., Daudelin, G. (2016). Responsible research and innovation: a productive model for the future of medical innovation, Journal of Responsible Innovation, doi: 10.1080/23299460.2016.1256659

This article aims to generate a better understanding of the historical Research & Development dynamics that have contributed to shape today’s medical innovation ecosystem.

Lehoux, P., Roncarolo, F., Rocha Oliveira, R., Pacifico Silva, H. (2016). Medical innovation and the sustainability of health systems: A historical perspective on technological change in health, Health Services Management Research, doi: 10.1177/0951484816670192

This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process.

Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist. Science & Public Policy. doi: 10.1093/scipol/scv051

This paper clarifies why technology developers are pushed to prioritize design features that expedite sales, often to the detriment of design features that would increase the clinical value of their technology.

Lehoux et al. (2014). How do business models and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs. Research Policy. 43(6):1025-1038.

This book explains how health technology is embedded in broader social and political practices that can be reshaped through appropriate policy initiatives. It was short-listed along 3 others for the 2007 Best Book Award of the British Sociology Association and Sociology of Health & Illness.

Lehoux (2006). The problem of health technology. Policy implications for modern health care systems. New York: Routledge.

Leave a Reply

Your email address will not be published. Required fields are marked *